Awards & Advancement

Centauri Therapeutics receives Innovate UK Biomedical Catalyst Award

Tuesday, September 12, 2017

Centauri Therapeutics, a biotechnology company focused on the treatment of infectious diseases and cancer, has been awarded up to £945,000 under Innovate UK’s Biomedical Catalyst (BMC) program. Alongside backing from the company’s investors, this award from the U.K.’s innovation agency will co-fund research focused on antimicrobial resistance. The project aims to generate a clinical candidate drug against Gram-negative bacteria, which are a major cause of mortality in hospital-acquired pneumonias, using the company’s Alphamer technology.

[Read More]

Piramal Pharma Solutions names John Fowler COO

Tuesday, September 12, 2017

Piramal Pharma Solutions (PPS), part of Piramal Enterprises Limited, announce the appointment of John Fowler as its Chief Operating Officer. PPS is a leader in Integrated Contract Development and Manufacturing, with a global network of 12 development and manufacturing facilities across North America, Europe and Asia. PPS offers a comprehensive range of services including Drug Discovery Solutions, Process & Pharmaceutical Development services, Clinical Trial Supplies and Commercial supply of APIs and Finished dosage forms. As Chief Operating Officer, John will be responsible for Global Operations and Research & Development (R&D), and will play a lead role in ensuring that our customers consistently experience differentiated and excellent levels of service.

[Read More]

NCI’s Douglas R. Lowy and John T. Schiller to receive 2017 Lasker Award

Friday, September 8, 2017

Two scientists at the National Cancer Institute (NCI) will receive the 2017 Lasker-DeBakey Clinical Medical Research Award for their significant research leading to the development of human papillomavirus (HPV) vaccines. The award is the country’s most prestigious biomedical research prize, and will be presented to John T. Schiller, Ph.D., of NCI’s Center for Cancer Research (CCR), and Douglas R. Lowy, M.D., also in CCR and acting director of NCI. NCI is part of the National Institutes of Health.

[Read More]

Cmed celebrates one year anniversary of encapsia

Tuesday, September 5, 2017

Cmed announced its one-year anniversary of the launch of encapsia, an innovative cloud-based clinical data suite of Apps that helps biotech and pharma sponsors transform the way data is captured, monitored and reviewed in clinical trials. The app-based solution is now being used by eight pharma companies, including two of the top five, for a variety of EDC and direct data capture eSource clinical trials.

[Read More]

Bain Capital, Cinven to nominate Claudio Albrecht CEO and CFO of STADA

Tuesday, September 5, 2017

Bain Capital and Cinven announce their intention to nominate Claudio Albrecht as new Chief Executive Officer and Mark Keatley as new Chief Financial Officer of STADA Arzneimittel. Prior to this, the current CEO Engelbert Coster Tjeenk Willink and CFO Dr Bernhard Düttmann had announced at the STADA Annual General Meeting that they would be ready to step down from their interim positions before expiry of their contracts following the successful completion of the public takeover by Bain Capital and Cinven. In line with German Corporate Governance, the actual appointment of Claudio Albrecht and Mark Keatley will be decided upon by the Supervisory Board of STADA once its new members have been appointed by Court.

[Read More]

Clintec presented with Queens Award for Enterprise – International Trade

Tuesday, September 5, 2017

Clintec, a global full service CRO, has been presented with the Queens Award for Enterprise 2017, in the category of International Trade by Lord Provost Eva Bolander in her capacity as Lord Lieutenant. The award ceremony coincides with the company’s continued expansion, with the official opening of an additional 4327sq feet floor at Clintec’s Glasgow-based headquarters, with the additional space forming a fully dedicated center of excellence for clinical research and quality assurance capabilities.

[Read More]